Implications of the 2024 American Heart Association Classification of Cardiac Sarcoidosis: Characteristics and Outcome of Patients Across the Continuum of Diagnostic Likelihood | Synapse
March 15, 2026Open Access
Implications of the 2024 American Heart Association Classification of Cardiac Sarcoidosis: Characteristics and Outcome of Patients Across the Continuum of Diagnostic Likelihood
Puntos clave
To examine the implications of the 2024 AHA classification on cardiac sarcoidosis outcomes.
Analyzed diagnostic likelihood groups based on 2024 AHA classification.
Evaluated clinical characteristics across different groups.
Conducted statistical analysis to assess prognostic value.
Identified differences in clinical characteristics among groups.
Statistical analysis indicated that the classification lacked independent prognostic value.
Resumen
The 2024 AHA stratification of CS likelihood distinguishes groups with differences in clinical characteristics but did not have independent prognostic value in our statistical analysis.